Life Sciences consortium celebrate collective multi-million Biomedical Catalyst 2023 Innovate UK grant

Press Release: 24th July 2023

Photo:  From left to right: Prof Carrie Ambler, (LightOx) Dr Sam Whitehouse (LightOx), Dr Fozia Saleem (Magnitude Biosciences), Chi Onwurah (Labour MP and Shadow Minister for Science Research and Digital), Olusola (Sola) Idowu (Hexis Lab), Dr Andrew Pike (NunaBio)

Newcastle based Life Sciences and Biomedical businesses, LightOx, NunaBio, Magnitude Biosciences and Hexis Lab are celebrating securing several awards to bring a pot of over £2.5million from Innovate UK’s latest round of R&D grants. InnovateUK provides the UK’s most innovative companies grant funding to help accelerate the  growth of our most innovate companies, and leverage private sector investment in the region. Through the support of advocates such as Labour’s Shadow Science MP Chi Onwurah, the region is able to demonstrate our capability and excellence in commercialising our scientific breakthroughs.

The funding will be used to advance the pharmaceutical and biotechnology research services, technology and drug development of these stand out companies. Innovate UK, part of UK Research and Innovation, have invested up to £25 million in a range of projects across the country this year. Supporting UK businesses to develop solutions that address significant health or healthcare challenges. From cancer prevention, development of new DNA based drug products,  testing regimes and tailored treatments the group are collectively transforming the delivery of healthcare and the development of new health technologies. 

With the North East fast becoming a hot bed of talent and innovation, the notable rise in Life Sciences and Biomedical companies in the region are proud to call it their home. An industry that has been supported not only through available funding but by key advocates including Labour’s Shadow Science MP Chi Onwurah, who has been lending her voice  as shadow science minister to the sector in Westminster and beyond. A voice that has most importantly helped in levelling up available investment and encouraging more of that funding back into the region. 

What our leaders have to say:

“The UK’s fantastic Life Science sector is the envy of countries across the world and a reflection of our brilliant science base and proud history of scientific discovery. These companies are addressing critical areas of discovery in medicine, vaccines and biochemical manufacturing, the Life Sciences sector is not only key to extending our quality of life, but also is crucial to a high wage, high growth, high skill, high productivity economy we all want to see.

Labour recognises that Life Sciences must be a central part of any growth strategy and crucial to building regional economies like here in the North East. LightOx, NunaBio, Magnitude Biosciences and Hexis Lab are shining examples of the innovation we have here on our doorstep and the award of the grants will only go to support them further on their growth journeys.  Delivering pioneering solutions and helping to put the North East firmly on the map.”  

Chi Onwurah MP & Shadow Minister for Science Research and Digital

“We are delighted to have secured the Innovate UK Biomedical Catalyst R&D grant alongside our superb neighbours and collaborators. These awards come at an important part of our business journey, and I am sure this support will help grow all our companies. The health and life sciences sector presents a huge number of opportunities for the North East and it’s been great to have the support of MP Chi Onwurah and to see the interest and levels of investment benefitting so many fellow businesses in the region.”

Dr Sam Whitehouse, Chief Executive Officer at LightOx and NELEP Board Member

“We are thrilled to have been awarded a Future Economy Investor Partnerships grant by Innovate UK. We have already developed our own novel imaging technology WormGazerTM to monitor the effects of compounds on C. elegans. This grant will enable further automation to increase through-put of compounds that can be screened, thus dramatically increasing the chances that customers will find potentially effective compounds. Having support from MP Chi Onwurah and other start-ups in the region allows us to put the North-East on the map and will really help with talent retention and acquisition too.”

Dr Fozia Saleem, Chief Executive Officer at Magnitude Biosciences

“Securing the Innovate UK funding is a game changer for us and our partner in this joint venture Teesside University.  The funding enables us to take our current early-stage research, and prove the science on a larger scale, creating sustainable alternatives for the cosmetic and pharmaceutical industry.  Having high level support from someone like our local MP is going to further strengthen the opportunities we have here in the North East to capitalise on the incredible talent we have here in the region, and help that talent to stay here further strengthening the opportunities for employers and employees in the North East.”

Dr Olusola (Sola) Idowu, Chief Executive Officer at Hexis Lab

See what the media says about our success:

The Northern Echo
Business Live
Insider Media
Bdaily News

To find out how Magnitude Biosciences can support your research contact us via 

Press Contact:

Jessica Evans

Related News

Magnitude Biosciences: Revolutionising Research
Contract research organisation Magnitude Biosciences is projecting significant growth as it looks to...Read More
Life Sciences consortium celebrate collective multi-million Biomedical Catalyst 2023 Innovate UK grant
Press Release: 24th July 2023 Photo:  From left to right: Prof Carrie Ambler, (LightOx) Dr Sam Whit...Read More
Magnitude Biosciences awarded grant to accelerate the identification of compounds that could slow ageing or treat age-related diseases
Photo: The Magnitude Biosciences Team May 2023, Sedgefield, United Kingdom Magnitude Biosciences Lim...Read More
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevit...Read More
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth
North East UK Biotech Magnitude Biosciences announces new CEO, Fozia Saleem, to accelerate the growt...Read More
SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics
Biotech entrepreneur Ethan Perlstein works with Magnitude Biosciences to reveal a new target for age...Read More
Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing
The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing res...Read More
Magnitude Biosciences, Perfectus Biomed Group and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting Biofilms
The joint project for Magnitude Biosciences, Perfectus Biomed Group and the University of Kent aims ...Read More
Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand
Durham, UK - July 29, 2021 Magnitude Biosciences, the world’s leading commercial lab services prov...Read More
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
Magnitude Biosciences secures its second round of funding to support its pre-clinical research servi...Read More
Magnitude Biosciences announces new hires to support continued growth
Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading con...Read More
Magnitude Biosciences secures UK government Future Fund to expand its workforce.
Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs acr...Read More
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research
Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More

Get regular updates in your inbox

Sign up to our newsletter today, to get access to the latest company and industry news